BF-UCP190F

· Olympus Europe SE & Co. KG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BF-UCP190F, covering 2025-11-28 to 2025-11-28. Get the full timeline:

Most recent: Clinical Trial Update: The LUCENT Study - LUng Lesion Assessment Via BF-UCP190F for Central and Extended Nodal Targeting